StockData
Aktis Oncology, Inc. logo

Aktis Oncology, Inc. (AKTS) stock

AKTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$16.10−0.21 (-1.29%)

Close on Nov 18, 2026Market cap $895.47MP/E –Yield –

Aktis Oncology cash

Cash and short-term investments held at the end of each period.

Aktis Oncology's cash was $492.90M at Sep 30, 2026. For fiscal 2025 it was $37.78M, down 1.4% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$37.78M-1.4%
FY2024Dec 31, 2024$38.31M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$492.90M+173.4%
Q2 FY2026Jun 30, 2026$517.30M+369.4%
Q1 FY2026Mar 31, 2026$538.50M+824.5%
Q4 FY2025Dec 31, 2025$37.78M-1.4%
Q3 FY2025Sep 30, 2025$180.25M–
Q2 FY2025Jun 30, 2025$110.22M–
Q1 FY2025Mar 31, 2025$58.25M–
Q4 FY2024Dec 31, 2024$38.31M–

More Aktis Oncology figures

See a number that looks wrong?